Supernus Pharmaceuticals, Inc. (SUPN) has a market capitalization of $2.89B and trades at $50.11. The 52-week range is 29.16-59.68.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -73.7, Earnings Per Share (EPS) of $-0.68, annual revenue of $718.95M.
The stock has a beta of 0.73, operates in the Healthcare sector.
